Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice. - Wikidata - wikimedia - TriplyDB

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

http://www.wikidata.org/entity/Q35176918

about

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation.Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades.Advances in Antiviral Therapies Targeting Toll-like Receptors.Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.Intein-mediated backbone cyclization of entolimod confers enhanced radioprotective activity in mouse models.

P2860

Q28075204-6F31C515-3627-4469-9B57-94DBD16C11E4 Q36607439-C2989BEE-5832-46A7-969E-48D4AE16E73D Q36771989-C5702C04-DBCD-4F9E-837F-FE4B865D4BA3 Q37702300-0865F0B9-2B6E-4898-9899-DC2494CBC87D Q38460376-19D680D1-70FA-4A3A-A06C-2353909AA8AA Q38610456-B04CD0FA-B060-4D3B-BCFC-6AF76B48464D Q38733975-EA0DE30C-F384-4E07-8AA5-14C496728194 Q40302307-63F03B47-E9C6-4422-A32B-78E06ED0724A Q55285439-DE690F46-AABD-46B0-8D5D-6013D46B368D

P2860

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

http://www.wikidata.org/entity/Q35176918

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

@ast

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

@en

type

label

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

@ast

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

@en

prefLabel

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

@ast

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

@en

P1433

Q35176918-404EA05D-EB1E-4096-9541-D796A81B1635

P1476

Q35176918-6C74473F-99E7-45D7-800B-9669F2EB1D46

P2093

Q35176918-850707FD-52EE-4507-854C-A8DB33273BF0

Q35176918-8E882522-604F-4C76-A275-F7149DD53AB9

Q35176918-B20CAC21-AFC2-486E-B3F2-278F79973984

Q35176918-FCB62FEA-BA22-4450-A58D-1B66B6F36F88

P2860

Q35176918-0702F388-650A-429A-BC7A-35D427E2A9DA

Q35176918-1F96C47A-2636-4869-AB9F-CC6D91E577BC

Q35176918-206CB33D-4DD9-45C2-8B0E-10B6805F4672

Q35176918-2F312097-B3F5-48AC-BA9F-8E94216DD051

Q35176918-3FD853EE-B62B-4D26-B946-E3748046E504

Q35176918-5069D364-6EBB-4404-8A7D-3B5E74A99EF7

Q35176918-51433251-D536-43C5-81BC-7B7661851752

Q35176918-5C2EC313-50B3-4CD4-AC12-D562F7A28543

Q35176918-6107A48F-0935-49BA-ABFC-44EFCE2E0146

Q35176918-6317F1FE-AB24-4691-A1F7-2A64038BE623

P304

Q35176918-87DC6085-B2E1-4FD9-8957-A679DF405FD2

P31

Q35176918-88824C72-D4F0-4DBB-9EF9-13E94DACD957

P356

Q35176918-057849C4-32B7-434C-BD46-E35CFD372951

P407

Q35176918-A3D8F29E-45A7-44CB-B18D-149C47660D0A

P433

Q35176918-D0672A8C-1706-4D0D-AA79-9C602AD8A373

P478

Q35176918-519FE56E-A8F3-455F-A91C-9928C682B9AA

P577

Q35176918-BC54545F-3A27-4271-9F99-E5CE6D3336CB

P5875

Q35176918-D3999BBB-C6FB-4446-B1AC-18B8031B8855

P698

Q35176918-06F0380D-4312-4FAF-8E88-051A76A20548

P921

Q35176918-C4FF7098-5B0B-4C5A-8D74-413341BC6AAE

P932

Q35176918-663D109C-E7DE-4EC5-80CA-64B30F5B0B4E

P356

JOURNAL.PONE.0096165

P1433

P1476

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

@en

P2093

Andrew T Gewirtz

http://www.w3.org/2001/XMLSchema#string

Edmund K Waller

http://www.w3.org/2001/XMLSchema#string

Mohammad S Hossain

http://www.w3.org/2001/XMLSchema#string

Sampath Ramachandiran

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis of TLR5-flagellin recognition and signaling

Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection

Host-reactive CD8+ memory stem cells in graft-versus-host disease

Up on the tightrope: natural killer cell activation and inhibition

A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.

An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models.

Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice

Development of murine hepatic NK cells during ontogeny: comparison with spleen NK cells.

Cytokine dysregulation and acute graft-versus-host disease.

Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity

P304

e96165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0096165

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262785067

http://www.w3.org/2001/XMLSchema#string

P698

24879439

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4039429

http://www.w3.org/2001/XMLSchema#string